Cardiovasc Toxicol. 2026 Jan 21;26(2):18. doi: 10.1007/s12012-026-10091-1.
ABSTRACT
Hypoxia is involved in severe cardiac conditions such as heart failure and myocardial infarction. Therefore, understanding the molecular mechanisms underlying hypoxia is crucial for developing effective therapeutic strategies. Specifically, one in vitro hypoxia model involves reducing oxygen concentration, thereby emulating many features observed in cardiac ischemia in rodents and patients. One way to overcome the infrastructure challenges in basic research laboratories (e.g., anaerobic chamber) is to use chemically-induced hypoxia models. Cobalt chloride (CoCl) treatment provides an inexpensive, accessible, and highly reproducible model in diverse cell types, as it mimics many of the cellular processes activated during hypoxia/ischemia. Paradoxically, no compendium addresses these processes beyond oxidative stress, let alone focusing on cardiac tissue. Hence, our objective was to describe how other processes, such as mitochondrial dysfunction, calcium handling, apoptosis, autophagy, inflammation, and endoplasmic reticulum stress, interact negatively in cardiac cells exposed to CoCl and to examine their cardiomyocyte-level toxicological effects.
PMID:41563660 | DOI:10.1007/s12012-026-10091-1